Vishwas Seshadri
Chief Executive Officer at Abeona Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Abeona Therapeutics Inc., 3 years.
Abeona Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Abeona Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | Abeona Therapeutics Inc. | Open-market sale | −67,971 | $6.96 | $473,330 |
| Jun 9, 2026 | Abeona Therapeutics Inc. | Open-market sale | −31,916 | $5.30 | $169,155 |
| Jun 8, 2026 | Abeona Therapeutics Inc. | Open-market sale | −24,428 | $5.43 | $132,644 |
| Mar 31, 2026 | Abeona Therapeutics Inc. | Open-market sale | −29,985 | $4.38 | $131,334 |
| Jan 22, 2026 | Abeona Therapeutics Inc. | Open-market sale | −69,832 | $5.33 | $372,205 |
| Jan 20, 2026 | Abeona Therapeutics Inc. | Grant or award | +365,422 | — | — |
| Dec 29, 2025 | Abeona Therapeutics Inc. | Open-market sale | −25,000 | $5.31 | $132,750 |
| Oct 16, 2025 | Abeona Therapeutics Inc. | Open-market sale | −249 | $5.49 | $1,367 |
| Sep 30, 2025 | Abeona Therapeutics Inc. | Open-market sale | −25,000 | $5.24 | $131,000 |
| Sep 29, 2025 | Abeona Therapeutics Inc. | Open-market sale | −19,274 | $5.39 | $103,887 |
| Jul 9, 2025 | Abeona Therapeutics Inc. | Open-market sale | −69,420 | $5.86 | $406,801 |
| Jun 6, 2025 | Abeona Therapeutics Inc. | Open-market sale | −50,676 | $6.76 | $342,570 |
| Jun 1, 2025 | Abeona Therapeutics Inc. | Shares withheld for tax | −885 | $6.24 | $5,522 |
| Mar 31, 2025 | Abeona Therapeutics Inc. | Open-market sale | −25,000 | $4.78 | $119,500 |
| Jan 21, 2025 | Abeona Therapeutics Inc. | Grant or award | +476,435 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.